Baidu
map
J BONE ONCOL 润色咨询

Journal of Bone Oncology

出版年份:暂无数据 年文章数:398 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:16.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=169112687, cover=https://img.medsci.cn/images/journal/cover/2021/mbn_202109271315316990.jpg, fullname=Journal of Bone Oncology, abbr=J BONE ONCOL, pyear=暂无数据, frequence=Quarterly, articleNumbers=398, citedSelf2015=16.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2212-1374, greenSci=https://www.greensci.net/search?kw=2212-1374, scijournal=https://www.scijournal.org/impact-factor-of-J-BONE-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.296, medsciHotlight=3.555, medsciHotlight5year=3.40788, citescore=5.9, hIndex=24, impactFactor=3.4, orgnization=Elsevier GmbH, orgnizationUrl=, country=Germany, countryCn=德国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.journals.elsevier.com/journal-of-bone-oncology/, websiteHits=3229, guideForAuthor=http://www.elsevier.com/journals/journal-of-bone-oncology/2212-1374/guide-for-authors, guideForAuthorHits=814, submitWebsite=https://www.evise.com/evise/faces/pages/navigation/NavController.jspx?JRNL_ACR=JBO, submitWebsiteHits=1853, content=<p style="box-sizing: border-box; margin: 0px 0px 1.5rem; padding: 0px; vertical-align: baseline; font-family: NexusSerif, Georgia, serif; font-size: 1.15rem; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; color: rgb(80, 80, 80);"><em style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit;">Journal of Bone Oncology</em> is an <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">open access journal</span> and is indexed in Clarivate Analytics'''' Journal Citation Reports/Science Edition as well as PubMedCentral<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline;"></p><p style="box-sizing: border-box; margin: 0px 0px 1.5rem; padding: 0px; vertical-align: baseline; font-family: NexusSerif, Georgia, serif; font-size: 1.15rem; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; color: rgb(80, 80, 80);">The <em style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit;">Journal of Bone Oncology</em> is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">bone</span>and <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">cancer</span>.</p><p style="box-sizing: border-box; margin: 0px 0px 1.5rem; padding: 0px; vertical-align: baseline; font-family: NexusSerif, Georgia, serif; font-size: 1.15rem; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; color: rgb(80, 80, 80);">As the first journal dedicated to <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">cancer induced bone diseases</span>, <em style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit;">JBO</em> welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.</p><p style="box-sizing: border-box; margin: 0px 0px 1.5rem; padding: 0px; vertical-align: baseline; font-family: NexusSerif, Georgia, serif; font-size: 1.15rem; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; color: rgb(80, 80, 80);">The areas covered by the journal include:</p><ul style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: 1.625rem; list-style-position: outside; font-family: NexusSans, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" font-size:="" 1.25rem;="" color:="" rgb(80,="" 80,="" 80);"=""><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone metastases</span> (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;">Preclinical models of <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">metastasis</span></li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone</span> microenvironment in <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">cancer</span> (stem cell, bone cell and cancer interactions)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone</span> targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Cancer</span> treatment induced <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">bone</span> loss (epidemiology, pathophysiology, prevention and management)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone</span> imaging (clinical and animal, skeletal interventional radiology)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone</span> biomarkers (clinical and translational applications)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;">Radiotherapy and radio-isotopes</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;">Skeletal complications</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Bone</span> pain (mechanisms and management)</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Orthopaedic cancer</span> surgery</li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;">Primary <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">bone tumours</span></li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;">Clinical <span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">guidelines</span></li><li style="box-sizing: border-box; margin: 0px 0px 0.5rem 1rem; padding: 0px; vertical-align: baseline; list-style: none; font-size: 1.15rem; line-height: 1.4; font-family: NexusSerif, Georgia, serif; position: relative;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Multidisciplinary</span> care</li></ul><p style="box-sizing: border-box; margin: 1.5rem 0px; padding: 0px; vertical-align: baseline; font-family: NexusSerif, Georgia, serif; font-size: 1.15rem; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; color: rgb(80, 80, 80);"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; font-weight: 700;">Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour</span></p>, totalCites=1356, brief=J BONE ONCOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=169112687'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=65601, tagName=骨肉瘤甲基化, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=323, tagName=骨肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.93), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.09), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.8), GetImpactFactorCiteScoreListResponse(year=2023, citescore=5.9)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.348), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.886), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.192), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=6.144), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.296)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=104/321)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2212-1374[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Journal of Bone Oncology[ta], article_number=51, article_number_cn=17, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
J BONE ONCOL/Journal of Bone Oncology
ISSN
2212-1374
影响指数话题
预警等级
MedSci期刊指数
3.296 (MedSci实时期刊指数) | 3.40788 (5年期刊指数)
CiteScore值
5.9
h-index
24
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier GmbH 出版或管理
出版国家/地区
Germany 德国
出版周期
Quarterly
出版年份
暂无数据
是否OA
被收录情况
Science Citation Index Expanded
JCR分区
暂无数据
中科院分区
大类:医学 3区
小类:医学 3 区
Baidu
map
Baidu
map
Baidu
map